Value of dynamic 31P magnetic resonance spectroscopy technique in in vivo assessment of the skeletal muscle mitochondrial function in type 2 diabetes

Chinese Medical Journal

Volumn 125, Issue 2, 2012, Pages 281-286

  Wu, Fei Yun ^a   Tu, Hui Juan ^a   Qin, Bin ^a   Chen, Ting ^a   Xu, Hua Feng ^a   Qi, Jing ^a   Wang, De Hang ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Mitochondrial function; Phosphorus magnetic resonance spectroscopy; Skeletal muscle; Type 2 diabetes

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; CREATINE PHOSPHATE; PHOSPHATE; PHOSPHORUS;

ADULT; ARTICLE; CELL FUNCTION; CELL PH; CLINICAL ARTICLE; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENERGY METABOLISM; EXERCISE RECOVERY; FEMALE; HUMAN; IN VIVO STUDY; MALE; MITOCHONDRION; MUSCLE EXAMINATION; MUSCLE LEVEL; NON INSULIN DEPENDENT DIABETES MELLITUS; NON INVASIVE MEASUREMENT; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; QUADRICEPS FEMORIS MUSCLE; QUANTITATIVE ANALYSIS; REST; CHEMISTRY; METABOLISM; METHODOLOGY; MIDDLE AGED; MUSCLE MITOCHONDRION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SKELETAL MUSCLE;

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ADULT; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; MITOCHONDRIA, MUSCLE; MUSCLE, SKELETAL; PHOSPHATES; PHOSPHOCREATINE; PHOSPHORUS;

EID: 84862937775     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2012.02.022     Document Type: Article

References (23)

1. Kelley D, He J, Menshikova E, Ritov V. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 2002; 51: 2944-2950.
2. Petersen K, Befoy D, Dufour S, Dziura J, Ariyan C, Rothman D, et al. Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 2003; 300: 1140-1142.
3. Petersen K, Dufour S, Befoy D, Garcia R, Shulman GI. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 2004; 350: 664-671.
4. Stump C, Short K, Bigelow M, Schimke J, Sreekumaran N. Effect of insulin on human skeletal muscle mitochondrial ATP production, protein synthesis and mRNA transcripts. Proc Natl Acad Sci USA 2003; 100: 7996-8001.
5. Moller HE, Kurlemann G, Putzler M, Wiedermann D, Hilbich T, Fiedler B. Magnetic resonance spectroscopy in patients with MELAS. J Neurol Sci 2005; 229-230:131-9.
6. Kornblum C, Schroder R, Muller K, Vorqerd M, Eqqers J, Boqdanow M, et al. Creatine has no beneficial effect on skeletal muscle energy metabolism in patients with single mitochondrial DNA deletions: a placebo-controlled, double-blind 31P-MRS crossover study. Eur J Neurol 2005; 12: 300-309.
7. Alberti KG, Zimmet PZ. Definition, diagnosis, and classification of diabetes mellitus: and its complications: report of a WHO consultation. Part I: Diagnosis and classification of diabetes mellitus. Diabet Med 1998; 15: 539-553.
8. Harris RC, Hultman E, Nordesjo LO. Glycogen, glycolytic intermediates and high energy phosphates determined in biopsy samples of musculus quadriceps femoris of man at rest. Scand J Clin Lab Invest 1974; 33: 385-394.
9. Taylor DJ, Fore PJ, Styles P, Gadian DG, Radda GK. Bioenergetics of intact human muscles: A 31P nuclear magnetic resonance study. Mol Biol Med 1983; 1: 77-83.
10. Dickson LM, Rhodes CJ. Pancreatic beta-cell growth and survival in the onset of type 2 diabetes: a role for protein kinase B in the Akt? Am J Physiol Endocrinol Metab 2004; 287: E192-E198.
11. Dunchen MR. Section III: mitochondria, B-cell function, and type 2 diabetes-roles of mitochondrial in health and disease. Diabetes 2004; 53: S96-S102.
12. Asmann YW, Stump CS, Short KR. Skeletal muscle mitochondrial functions, mitochondrial DNA copy numbers, and gene transcript profiles in type 2 diabetic and nondiabetic subjects at equal levels of low or high insulin and euglycemia. Diabetes 2006; 55: 3309-3319.
13. Larson-Meyer DE, Newcomer BR, Hunter GR, Hetherinqton HP, Weinsier RL. 31P MRS measurement of mitochondrial function in skeletal muscle: reliability, force-level sensitivity and relation to whole body maximal oxygen uptake. NMR Biomed 2000; 13: 14-27.
14. Smith SA, Montain SJ, Zientara GP, Fielding RA. Use of phosphocreatine kinetics to determine the influence of creatine on muscle mitochondrial respiration: an in vivo 31P-MRS study of oral creatine ingestion. J Appl Physiol 2004; 96: 2288-2292.
15. Cea G, Bendahan D, Manners D, Hilton-Jones D, Lodi R, Styles P, et al. Reduced oxidative phosphorylation and proton efflux suggest reduced capillary blood supply in skeletal muscle of patients with DM and PM: a quantitative 31P MRS and MRI study. Brain 2002; 125: 1635-1645.
16. Park JH, Niermann KJ, Rader NM, Nelson AE, Das A, Lawton AR, et al. Muscle abnormalities in juvenile dermatomyositis patients: P-31 magnetic resonance spectroscopy studies. Arthritis Rheumatism 2000; 43: 2359-2367.
17. Pieczenik SR, Neustadt J. Mitochondrial dysfunction and molecular pathways of disease. Exp Mol Pathol 2007; 83: 84-92.
18. Lowell BB, Shulman GI. Mitochondrial dysfunction and type 2 diabetes. Science 2005; 307: 384-387.
19. Maechler P, Wollheim CB. Mitochondrial function in normal and diabetic β-cells. Nature 2001; 414: 807-182.
20. Phielix E, Mensink M. Type 2 diabetes mellitus and skeletal muscle metabolic function. Physiol Behav 2008; 94: 252-258.
21. Schrauwen-Hinderling VB, Kooi ME, Hesselink MK, Jeneson JA, Backes WH, van Enqelshoven JM, et al. Impaired in vivo mitochondrial function but similar intramyocellular lipid content in patientswith type 2 diabetesmellitus and BMI-matched control subjects. Diabetologia 2007; 50: 113-120.
22. Szendroedi J, Schmid AI, Chmelik M, Toth C, Brehm A, Krssak M, et al. Muscle mitochondrial ATP synthesis and glucose transport/phosphorylation in type 2 diabetes. PLoS Med 2007; 4: E154.
23. Green K, Brand MD, Murphy MP. Prevention of mitochondrial oxidative damage as a therapeutic strategy in diabetes. Diabetes 2004; 53: S110-S118.